Out-licensing

Messenger Biopharma will not develop mRNA vaccines and is not a CDMO.

We are eager to out-license our biotechnologies to pharmaceutical and biotech companies for the development of mRNA vaccines and therapies.

Last news

photo labo 2

Messenger Biopharma launches the commercialization of its Nuntius biotechnology

posted October 10, 2024

Read More